drugset / Trial / NCT06195319

Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-Simufilam Following a Single Oral Dose in Healthy Male Subjects

NCT06195319 ↗

Phase 1 Completed 8 enrolled Cassava Sciences, Inc.
Non-randomizedSingle-groupOpen-labelOther

Summary

To evaluate the absorption, metabolism, and excretion of \[14C\]-simufilam in healthy male subjects following a single oral administration of 100 mg of (approximately 100 µCi) \[14C\]-simufilam.

Timeline

Start
2024-02-07
Primary completion
2024-03-27
Completion
2024-03-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Simufilam Small molecule 100 mg Oral

Indications

No indication recorded.